Ligand Pharmaceuticals Incorporated Contracts & Agreements

216 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
SEPARATION AGREEMENT
Separation Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2012
Severance Agreement and General Release dated as of August 2, 2024, between Ligand Pharmaceuticals Incorporated and Mr. Korenberg
Severance Agreements
Ligand Pharmaceuticals Incorporated
2024
Agreement on the Acquisition of Stocks in Apeiron Biologics AG entered on July 8, 2024, between Ligand Pharmaceuticals Incorporated and the sellers
Ligand Pharmaceuticals Incorporated
2024
First Amendment to Credit Agreement, dated as of July 8, 2024, among Ligand Pharmaceuticals Incorporated, certain of its subsidiaries, as Guarantors, the Lenders, and Citibank,...
Credit Agreements
Ligand Pharmaceuticals Incorporated
2024
Purchase and Sale Agreement, dated May 6, 2024, byand among Ligand Pharmaceuticals Incorporated,Agenus Inc., Agenus Royalty Fund, LLC, and AgenusHoldings 2024, LLC
Purchase Agreements
Ligand Pharmaceuticals Incorporated
2024
Amendment to 2022 Employee Inducement Plan
Ligand Pharmaceuticals Incorporated
2024
Amendment No. 1 to Development Funding and Royalties Agreement, dated as of May 22, 2020, by and between the Company and Palvella Therapeutics, Inc
Development Agreements
Ligand Pharmaceuticals Incorporated
2024
Amendment No. 2 to Development Funding and Royalties Agreement, dated as of November 29, 2023, by and between the Company and Palvella Therapeutics, Inc
Development Agreements
Ligand Pharmaceuticals Incorporated
2024
Director Compensation and Stock Ownership Policy, as amended and restated effective August 4, 2023
Stock Agreements
Ligand Pharmaceuticals Incorporated
2023
Director Compensation and Stock Ownership Policy, as amended and restated effective April 19, 2023
Stock Agreements
Ligand Pharmaceuticals Incorporated
2023
Form of Change in Control Severance Agreement
Change of Control Agreements
Ligand Pharmaceuticals Incorporated
2023
Amended and Restated Severance Plan, effective November 1, 2022
Severance Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2023
Director Compensation and Stock Ownership Policy, as amended and restated, effective April 13, 2020
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2023
Separation Agreement , effective December 12, 2022, by and between Ligand Pharmaceuticals Incorporated and John Higgins
Separation Agreements
Ligand Pharmaceuticals Incorporated
2023
Severance Agreement, effective December 5, 2022, by and between Ligand Pharmaceuticals Incorporated and Todd C. Davis
Severance Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2023
Amended and Restated Employee Matters Agreement, dated as of August 18, 2022, by and among Ligand Pharmaceuticals Incorporated, OmniAb Operations, Inc. (f/k/a OmniAb, Inc.),...
Merger Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2022
Tax Matters Agreement, dated as of November 1, 2022, by and among Ligand Pharmaceuticals Incorporated, OmniAb Operations, Inc. and OmniAb, Inc
Ligand Pharmaceuticals Incorporated
2022
2022 Employment Inducement Plan
Employment Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2022
Form of Stock Option Agreement under the Companys 2022 Employment Inducement Plan
Stock Agreements
Ligand Pharmaceuticals Incorporated
2022
Form of Restricted Stock Unit Award Agreement under the Companys 2022 Employment Inducement Plan
Stock Agreements
Ligand Pharmaceuticals Incorporated
2022
Form of Performance-Based Restricted Stock Unit Award Agreement under the Companys 2022 Employment Inducement Plan
Bonus & Incentive Agreements
Ligand Pharmaceuticals Incorporated
2022
Sublicense Agreement between the Company, Pharmacopeia, Inc. and Retrophin LLC dated as of February 16, 2012, as amended through Amendment No. 5 to Sublicense Agreement, dated...
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2022
Lease, dated June 8, 2021, between the Company and Emery Station Office II, LLC
Lease Agreements
Ligand Pharmaceuticals Incorporated
2022
Description of Registered Securities
Ligand Pharmaceuticals Incorporated
2021
2002 Stock Incentive Plan (as amended and restated effective December 15, 2020)
Bonus & Incentive Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2021
Call Option Amendment Agreed, dated January 28, 2021, between the Registrant and Barclays Bank PLC
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2021
Call Option Amendment Agreed, dated January 28, 2021, between the Registrant and Deutsche Bank AG, London Branch
Ligand Pharmaceuticals Incorporated
2021
Call Option Amendment Agreed, dated January 28, 2021, between the Registrant and Goldman Sachs & Co. LLC
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2021
Supply agreement, dated December 22, 2015, by and between Cydex Pharmaceuticals, Inc. and Gilead Sciences, Inc
Supply Agreements
Ligand Pharmaceuticals Incorporated
2021
Contingent Value Rights Agreement, dated as of September 30, 2020, by and between Ligand Pharmaceuticals Incorporated and American Stock Transfer & Trust Company, LLC
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2020
Amendment to Supply Agreement, dated September 21, 2020, by and between Cydex Pharmaceuticals, Inc. and Gilead Sciences, Inc., which amends that certain Supply Agreement, dated...
Supply Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2020
Agreement and Plan of Merger among Ligand Pharmaceuticals Incorporated, xCella Biosciences, Inc. and other persons, dated September 8, 2020
Merger Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
TX
2020
Agreement and Plan of Merger among Ligand Pharmaceuticals Incorporated, Taurus Biosciences, LLC and other persons, dated September 9, 2020
Merger Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2020
Contingent Value Rights Agreement between Ligand Pharmaceuticals Incorporated and Vaughn Smider, as Members Representative (regarding Taurus Biosciences, LLC acquisition), dated...
Ligand Pharmaceuticals Incorporated
2020
Commercial License Agreement between Taurus Biosciences, LLC and Minotaur Therapeutics, Inc., dated September 9, 2020
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2020
Agreement and Plan of Merger, dated as of August 10, 2020, by and among Pfenex, Inc., Ligand Pharmaceuticals Incorporated and Pelican Acquisition Sub, Inc
Merger Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2020
Asset Purchase Agreement, dated February 11, 2020, (as amended on April 1, 2020), by and among the Registrant, Icagen Inc., Icagen Corp., XRPro Sciences, Inc. and Caldera...
Purchase Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2020
Call Option Amendment Agreed, dated April 6, 2020, between the Registrant and Barclays Bank PLC
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2020
Call Option Amendment Agreed, dated April 6, 2020, between the Registrant and Deutsche Bank AG, London Branch
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2020
Call Option Amendment Agreed, dated April 6, 2020, between the Registrant and Goldman Sachs & Co. LLC
Ligand Pharmaceuticals Incorporated
2020
Description of Registered Securities
Ligand Pharmaceuticals Incorporated
Biotechnology
2020
Amended and Restated Director Compensation and Stock Ownership Policy, effective March 28, 2019
Stock Agreements
Ligand Pharmaceuticals Incorporated
2020
Sublicense Agreement between the Company, Pharmacopeia, Inc. and Retrophin LLC dated as of February 16, 2012, as amended through Amendment No. 5 to Sublicense Agreement, dated...
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2020
Addendum, dated May 22, 2019, by and among Ligand Pharmaceuticals Incorporated, CyDex Pharmaceuticals, Inc. and Acrotech Biopharma LLC (as successor-in-interest to Spectrum...
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2019
Asset Purchase Agreement, dated March 5, 2019, by and among Ligand Pharmaceuticals Incorporated and RPI Finance Trust
Purchase Agreements
Ligand Pharmaceuticals Incorporated
2019
Development Funding and Royalties Agreement, dated December 13, 2018, by and between Ligand Pharmaceuticals Incorporated and Palvella Therapeutics, Inc
Development Agreements
Ligand Pharmaceuticals Incorporated
2019
Rule 2.7 Announcement issued by Ligand Holdings UK Ltd., dated August 9, 2018
Ligand Pharmaceuticals Incorporated
2018
Cooperation Agreement, dated August 9, 2018, by and between Vernalis plc and Ligand Holdings UK Ltd
Cooperation Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2018
Break Fee Agreement, dated August 9, 2018, by and between Vernalis plc and Ligand Holdings UK Ltd
Ligand Pharmaceuticals Incorporated
Biotechnology
2018
Supplemental Indenture, dated as of February 20, 2018, between the Company and Wilmington Trust, National Association, as trustee
Indenture Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2018
LIGAND PHARMACEUTICALS INCORPORATED AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of May 22, 2018 0.75% Convertible Senior Notes due 2023 TABLE OF...
Indenture Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2018
Letter Agreement, dated as of May 17, 2018, between Barclays Capital Inc. and the Company regarding the Base Convertible Note Hedge Transaction
Note Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2018
Letter Agreement, dated as of May 17, 2018, between Barclays Capital Inc. and the Company regarding the Base Warrant Transaction
Warrant Agreements
Ligand Pharmaceuticals Incorporated
2018
Letter Agreement, dated as of May 17, 2018, between Deutsche Bank AG and the Company regarding the Base Convertible Note Hedge Transaction
Note Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2018
Letter Agreement, dated as of May 17, 2018, between Deutsche Bank AG and the Company regarding the Base Warrant Transaction
Warrant Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2018
[Signature Page Follows]
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2018
Letter Agreement, dated as of May 18, 2018, between Barclays Capital Inc. and the Company regarding the Additional Convertible Note Hedge Transaction
Note Agreements
Ligand Pharmaceuticals Incorporated
2018
Letter Agreement, dated as of May 18, 2018, between Barclays Capital Inc. and the Company regarding the Additional Warrant Transaction
Warrant Agreements
Ligand Pharmaceuticals Incorporated
2018
Letter Agreement, dated as of May 18, 2018, between Deutsche Bank AG and the Company regarding the Additional Convertible Note Hedge Transaction
Note Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2018
Letter Agreement, dated as of May 18, 2018, between Deutsche Bank AG and the Company regarding the Additional Warrant Transaction
Warrant Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2018
Letter Agreement, dated as of May 18, 2018, between Goldman Sachs & Co. LLC and the Company regarding the Additional Warrant Transaction
Warrant Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2018
Amendment No. 5 to Sublicense Agreement, dated March 20, 2018, among the Company, Pharmacopeia, LLC and Retrophin, Inc
Ligand Pharmaceuticals Incorporated
2018
License Agreement, dated March 5, 2018, by and between the Company and Roivant Sciences GmbH
License Agreements
Ligand Pharmaceuticals Incorporated
2018
Agreement and Plan of Merger, dated as of October 4, 2017, by and among Ligand Pharmaceuticals Incorporated, Eagle Acquisition, Inc., Crystal Bioscience, Inc. and Shareholder...
Merger Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2017
Third Amendment to Loan and Security Agreement
Loan Agreements
Ligand Pharmaceuticals Incorporated
2017
LIGAND PHARMACEUTICALS INCORPORATED DIRECTOR COMPENSATION AND STOCK OWNERSHIP POLICY (Amended and Restated Effective March [ ], 2014) I. DIRECTOR COMPENSATION
Stock Agreements
Ligand Pharmaceuticals Incorporated
2016
SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2016
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY...
Exchange Agreements
Ligand Pharmaceuticals Incorporated
2016
Consent of Independent Registered Public Accounting Firm
Ligand Pharmaceuticals Incorporated
2016
AGREEMENT AND PLAN OF MERGER BY AND AMONG LIGAND PHARMACEUTICALS INCORPORATED, SCHRADER 1 ACQUISITION, INC., SCHRADER 2 ACQUISITION, INC., OPEN MONOCLONAL TECHNOLOGY, INC., OMT,...
Merger Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2015
LEASE 3911/3931 SVB,LLC, a California limited liability company as Landlord, and LIGAND PHARMACEUTICALS INCORPORATED, a Delaware corporation, as Tenant. 3911Sorrento Valley...
Lease Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2015
AMENDMENT NO. 4 TO SUBLICENSE AGREEMENT
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2015
SECOND AMENDMENT TO MASTER LICENSE AGREEMENT
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2015
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Ligand Pharmaceuticals Incorporated
2015
FIRST AMENDMENT TO MASTER LICENSE AGREEMENT
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2014
LIGANDPHARMACEUTICALS INCORPORATED AS ISSUER 0.75% CONVERTIBLE SENIOR NOTES DUE 2019 INDENTURE DATED AS OF AUGUST 18, 2014 WILMINGTON TRUST, NATIONAL ASSOCIATION AS TRUSTEE TABLE...
Indenture Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2014
LOAN AND SECURITY AGREEMENT
Loan Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2014
MASTER LICENSE AGREEMENT Dated May 21, 2014 by and between Ligand Pharmaceuticals Incorporated and Metabasis Therapeutics, Inc., on one hand, and Viking Therapeutics, Inc., on the...
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2014
RESEARCH AND LICENSE AGREEMENT Dated as of May 9, 2014 by and between Ligand Pharmaceuticals Incorporated and Omthera Pharmaceuticals, Inc. RESEARCH AND LICENSE AGREEMENT
License Agreements
Ligand Pharmaceuticals Incorporated
2014
LICENSE AGREEMENT Dated as of June 23, 2014 by and between Ligand Pharmaceuticals Incorporated and TG Therapeutics, Inc. LICENSE AGREEMENT
License Agreements
Ligand Pharmaceuticals Incorporated
2014
AMENDMENT OF GENERAL CONTINGENT VALUE RIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
2014
AMENDMENT OF TR BETA CONTINGENT VALUE RIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
2014
LIGAND PHARMACEUTICALS INCORPORATED NOTICE OF GRANT OF STOCK OPTION
Stock Agreements
Ligand Pharmaceuticals Incorporated
2014
LICENSE AGREEMENT
License Agreements
Ligand Pharmaceuticals Incorporated
2013
RECITALS:
Ligand Pharmaceuticals Incorporated
2013
LICENSE AGREEMENT BETWEEN CYDEX PHARMACEUTICALS, INC. AND CURX PHARMACEUTICALS, INC. DATED: August 12, 2013 TABLE OF CONTENTS
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
MN
2013
SUPPLY AGREEMENT BETWEEN CYDEX PHARMACEUTICALS, INC. AND CURX PHARMACEUTICALS, INC. DATED: August 12, 2013 TABLE OF CONTENTS
Supply Agreements
Ligand Pharmaceuticals Incorporated
2013
LIGAND PHARMACEUTICALS INCORPORATED Common Stock (par value $0.001 per share) At the Market Issuance Sales Agreement
Stock Agreements
Ligand Pharmaceuticals Incorporated
2013
LIGAND PHARMACEUTICALS INCORPORATED DOCS ATM financing facility $24,000,000 of Common Stock, $0.001 par value SALES AGREEMENT October 11, 2013
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2013
ROYALTY STREAM AND MILESTONE PAYMENTS PURCHASE AGREEMENT
Purchase Agreements
Ligand Pharmaceuticals Incorporated
2013
FIRST AMENDMENT TO 2006 PREFERRED SHARES RIGHTS AGREEMENT June 19, 2013
Ligand Pharmaceuticals Incorporated
Biotechnology
2013
LICENSE AGREEMENT
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2013
SUPPLY AGREEMENT
Supply Agreements
Ligand Pharmaceuticals Incorporated
2013
SIXTH AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2013
AMENDED AND RESTATED LICENSE AGREEMENT
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2013
RESEARCH LICENSE AND OPTION AGREEMENT Dated April 27, 2012 By and Between Ligand Pharmaceuticals Incorporated and Ares Trading SA
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2012
SUBLICENSE AGREEMENT
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2012
SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Ligand Pharmaceuticals Incorporated
2012
LIGAND PHARMACEUTICALS INCORPORATED Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement
Stock Agreements
Ligand Pharmaceuticals Incorporated
2012
JOINDER AND SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Ligand Pharmaceuticals Incorporated
2012
LICENSE AGREEMENT BETWEEN CYDEX PHARMACEUTICALS, INC. AND ELI LILLY AND COMPANY DATED: December 16, 2011 TABLE OF CONTENTS
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2012
SUPPLY AGREEMENT BETWEEN CYDEX PHARMACEUTICALS, INC. AND ELI LILLY AND COMPANY DATED: December 16, 2011 TABLE OF CONTENTS
Supply Agreements
Ligand Pharmaceuticals Incorporated
2012
LICENSE AND SUPPLY AGREEMENT
License Agreements
Ligand Pharmaceuticals Incorporated
2012
FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2012
FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Ligand Pharmaceuticals Incorporated
2012
SECURED PROMISSORY NOTE
Note Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2012
SECURED PROMISSORY NOTE
Note Agreements
Ligand Pharmaceuticals Incorporated
2012
FIRST AMENDMENT TO LICENSE AGREEMENT
License Agreements
Ligand Pharmaceuticals Incorporated
2011
LEASE AGREEMENT
Lease Agreements
Ligand Pharmaceuticals Incorporated
2011
LICENSE AGREEMENT
License Agreements
Ligand Pharmaceuticals Incorporated
2011
LIGAND PHARMACEUTICALS INCORPORATED DIRECTOR COMPENSATION AND STOCKOWNERSHIP POLICY (Amended and Restated Effective June 1, 2011) I. DIRECTOR COMPENSATION
Compensation Agreements
Ligand Pharmaceuticals Incorporated
2011
LICENSE AGREEMENT
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NJ
2011
SUPPLY AGREEMENT
Supply Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2011
SUPPLY AGREEMENT
Supply Agreements
Ligand Pharmaceuticals Incorporated
2011
LICENSE AGREEMENT
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2011
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2011
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Ligand Pharmaceuticals Incorporated
2011
LIGAND PHARMACEUTICALS, INCORPORATED LOAN AND SECURITY AGREEMENT
Loan Agreements
Ligand Pharmaceuticals Incorporated
2011
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY...
Supply Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2011
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY...
Supply Agreements
Ligand Pharmaceuticals Incorporated
2011
2nd Amendment to the CAPTISOL® SUPPLY AGREEMENT dated as of December 20, 2002 and amended July 29, 2005 BY AND BETWEEN CYDEX, INC. AND THE HOVIONE GROUP Dated as of March 1, 2007...
Supply Agreements
Ligand Pharmaceuticals Incorporated
2011
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY...
Supply Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2011
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY...
Ligand Pharmaceuticals Incorporated
2011
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY...
License Agreements
Ligand Pharmaceuticals Incorporated
2011
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY...
Ligand Pharmaceuticals Incorporated
Biotechnology
2011
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY...
Ligand Pharmaceuticals Incorporated
Biotechnology
2011
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY...
License Agreements
Ligand Pharmaceuticals Incorporated
2011
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY...
License Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
KS
2011
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY...
Ligand Pharmaceuticals Incorporated
2011
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY...
Ligand Pharmaceuticals Incorporated
2011
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY...
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2011
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY...
Ligand Pharmaceuticals Incorporated
Biotechnology
2011
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY...
Ligand Pharmaceuticals Incorporated
2011
AMENDMENT OF GENERAL CONTINGENT VALUE RIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
2011
CERTIFICATE OF MERGER OF CAYMUS ACQUISITION, INC. (a Delaware corporation) WITH AND INTO CYDEX PHARMACEUTICALS, INC. (a Delaware corporation) Pursuant toSection 251 of the General...
Merger Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2011
AGREEMENT AND PLAN OF MERGER by and among: LIGAND PHARMACEUTICALS INCORPORATED, a Delaware corporation; CAYMUSACQUISITION, INC., a Delaware corporation; and CYDEX PHARMACEUTICALS,...
Merger Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
MO
2011
CONTINGENT VALUE RIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
2011
LOAN AND SECURITY AGREEMENT
Loan Agreements
Ligand Pharmaceuticals Incorporated
2011
ASSET PURCHASE AGREEMENT Dated as of July 30, 2010 By and Between WYETH LLC and PHARMACOPEIA, INC. and Solely for Purposes of the Specified Sections Herein LIGAND PHARMACEUTICALS...
Purchase Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2010
PURCHASE AGREEMENT BETWEEN BIOTECHNOLOGY VALUE FUND, L.P., ON ITS OWN BEHALF AND ON BEHALF OF BIOTECHNOLOGY VALUE FUND II, L.P. AND INVESTMENT 10, L.L.C. and LIGAND...
Purchase Agreements
Ligand Pharmaceuticals Incorporated
2010
PURCHASE AND SALE AGREEMENT
Purchase Agreements
Ligand Pharmaceuticals Incorporated
2010
AMENDMENT NUMBER ONE TO RESEARCH AND LICENSE AGREEMENT
License Agreements
Ligand Pharmaceuticals Incorporated
2010
AMENDMENT
Ligand Pharmaceuticals Incorporated
Biotechnology
2010
CERTIFICATE OF MERGER OF
Merger Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2010
CONTINGENT VALUE RIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
2010
CONTINGENT VALUE RIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2010
CONTINGENT VALUE RIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2010
CONTINGENT VALUE RIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
2010
CERTIFICATE OF MERGER OF
Merger Agreements
Ligand Pharmaceuticals Incorporated
2009
CONTINGENT VALUE RIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2009
CONTINGENT VALUE RIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
2009
CONTINGENT VALUE RIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2009
AMENDMENT NO. 3 TO AGREEMENT AND PLAN OF MERGER
Merger Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2009
AMENDMENT TO AGREEMENT AND PLAN OF MERGER
Merger Agreements
Ligand Pharmaceuticals Incorporated
2009
RESEARCH COLLABORATION TERMINATION AGREEMENT
Termination Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2009
AMENDMENT NO. 2 TO PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
Development Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2009
AMENDMENT TO AGREEMENT AND PLAN OF MERGER
Merger Agreements
Ligand Pharmaceuticals Incorporated
2009
AMENDMENT NO. 2 TO AGREEMENT AND PLAN OF MERGER
Merger Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2009
Form of Roche CVR Agreement CONTINGENT VALUERIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2009
Form of TR Beta CVR Agreement CONTINGENT VALUERIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2009
Form of General CVR Agreement CONTINGENT VALUERIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2009
VOTING AGREEMENT
Voting Agreements
Ligand Pharmaceuticals Incorporated
2009
AGREEMENT AND PLAN OF MERGER by and among: LIGAND PHARMACEUTICALS INCORPORATED, a Delaware corporation; NEON SIGNAL, LLC,
Merger Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2009
Form of Aplindore CVR Agreement CONTINGENT VALUE RIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2009
Form of H3 CVR Agreement CONTINGENT VALUE RIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
2009
Form of Merck CVR Agreement CONTINGENT VALUE RIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
2009
Form of Real Estate CVR Agreement CONTINGENT VALUE RIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2009
VOTING AGREEMENT
Voting Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2009
LEASE HCP TPSP, LLC Landlord AND
Lease Agreements
Ligand Pharmaceuticals Incorporated
2009
LEASE TERMINATION AGREEMENT
Lease Agreements
Ligand Pharmaceuticals Incorporated
2009
1 of 19
Ligand Pharmaceuticals Incorporated
2009
LIGAND PHARMACEUTICALS INCORPORATED DIRECTOR COMPENSATION AND STOCK OWNERSHIP POLICY (Amended and Restated Effective April 16, 2009) I. DIRECTOR COMPENSATION
Stock Agreements
Ligand Pharmaceuticals Incorporated
2009
ARTICLE 1 DEFINITIONS
Ligand Pharmaceuticals Incorporated
Biotechnology
NJ
2009
SEPARATION AGREEMENT
Separation Agreements
Ligand Pharmaceuticals Incorporated
2009
PHARMACOPEIA, INC. 2000 STOCK OPTION PLAN
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2009
By and Between PHARMACOPEIA, INC. and SCHERING-PLOUGH LTD. Table of Contents i COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2009
By and Between PHARMACOPEIA, INC. and SCHERING CORPORATION Table of Contents i COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
Ligand Pharmaceuticals Incorporated
2009
LEASE AGREEMENT BY AND BETWEEN: Eastpark at 8A Landlord
Lease Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2009
LEASE AGREEMENT BY AND BETWEEN: Eastpark at 8A Landlord
Lease Agreements
Ligand Pharmaceuticals Incorporated
2009
ARTICLE 1 DEFINITIONS
Ligand Pharmaceuticals Incorporated
2009
LIGAND PHARMACEUTICALS INCORPORATED AMENDED AND RESTATED SEVERANCE PLAN (AND SUMMARY PLAN DESCRIPTION)
Severance Agreements
Ligand Pharmaceuticals Incorporated
2008
SETTLEMENT AGREEMENT AND MUTUAL RELEASE OF ALL CLAIMS
Settlement Agreements
Ligand Pharmaceuticals Incorporated
2008
AGREEMENT AND PLAN OF MERGER
Merger Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2008
LIGAND PHARMACEUTICALS INCORPORATED 2002 STOCK INCENTIVE PLAN
Bonus & Incentive Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2008
AMENDMENT TO RESTRICTED STOCK AGREEMENT
Stock Agreements
Ligand Pharmaceuticals Incorporated
2008
AMENDMENT TO RESTRICTED STOCK AGREEMENT
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2008
No information provided due to inapplicability of item
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2007
Approved in March 2002 for sale in the U.S. for the once-daily treatment of moderate-to-severe pain in patients who require continuous, around-the-clock opioid therapy for an...
Ligand Pharmaceuticals Incorporated
Biotechnology
PA
2007
Approved in March 2002 for sale in the U.S. for the once-daily treatment of moderate-to-severe pain in patients who require continuous, around-the-clock opioid therapy for an...
Ligand Pharmaceuticals Incorporated
Biotechnology
2007
Approved in March 2002 for sale in the U.S. for the once-daily treatment of moderate-to-severe pain in patients who require continuous, around-the-clock opioid therapy for an...
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2007
PURCHASE AGREEMENT AND ESCROW INSTRUCTIONS
Escrow Agreements
Ligand Pharmaceuticals Incorporated
2006
No information provided due to inapplicability of item
Ligand Pharmaceuticals Incorporated
2006
SEPARATION AGREEMENT
Separation Agreements
Ligand Pharmaceuticals Incorporated
2006
RELEASE OF CLAIMS
Release Agreements
Ligand Pharmaceuticals Incorporated
2006
Common stock offered
Stock Agreements
Ligand Pharmaceuticals Incorporated
2006
Common stock offered
Stock Agreements
Ligand Pharmaceuticals Incorporated
2006
Common stock offered
Stock Agreements
Ligand Pharmaceuticals Incorporated
2006
Common stock offered
Stock Agreements
Ligand Pharmaceuticals Incorporated
2006
Common stock offered
Stock Agreements
Ligand Pharmaceuticals Incorporated
2006
Common stock offered
Stock Agreements
Ligand Pharmaceuticals Incorporated
2006
No information provided due to inapplicability of item
Ligand Pharmaceuticals Incorporated
Biotechnology
2005
CONTINGENT VALUE RIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2009
by and among: LIGAND PHARMACEUTICALSINCORPORATED, a Delaware corporation; MOONSTONE ACQUISITION, INC., a Delaware corporation; METABASIS THERAPEUTICS,INC., a Delaware corporation;...
Ligand Pharmaceuticals Incorporated
Biotechnology
2009
Form of Glucagon CVR Agreement CONTINGENT VALUERIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2009
CONTINGENT VALUE RIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2008
CONTINGENT VALUE RIGHTS AGREEMENT
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2008
Exhibit No
Ligand Pharmaceuticals Incorporated
Biotechnology
2007
No information provided due to inapplicability of item
Ligand Pharmaceuticals Incorporated
Biotechnology
2007
No information provided due to inapplicability of item
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2007
Approved in March 2002 for sale in the U.S. for the once-daily treatment of moderate-to-severe pain in patients who require continuous, around-the-clock opioid therapy for an...
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2007
Approved in March 2002 for sale in the U.S. for the once-daily treatment of moderate-to-severe pain in patients who require continuous, around-the-clock opioid therapy for an...
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2007
No information provided due to inapplicability of item
Ligand Pharmaceuticals Incorporated
Biotechnology
2006
No information provided due to inapplicability of item
Ligand Pharmaceuticals Incorporated
Biotechnology
2006
No information provided due to inapplicability of item
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2005
No information provided due to inapplicability of item
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2005
No information provided due to inapplicability of item
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2005